RICHMOND, Ind. (May 7, 2025) Liberation Labs today announced a manufacturing partnership with Dutch ingredients startup Vivici. Liberation Labs will produce Vivici’s flagship ingredient, Vivitein^TM BLG, at its Richmond, Indiana, facility when commercial production begins in 2026. 

The New Standard of Protein, Vivitein™ BLG, is a dairy protein (beta-lactoglobulin) produced through precision fermentation, enabling B2B customers to launch disruptive, differentiated, and better overall products to consumers in the US market. These include clear water-based protein drinks with innovative flavors, clean protein powders with superior muscle-building performance and rapid absorption, and vegan-friendly protein bars with luscious chewy textures.

“Vivici is a perfect reference case for our facility - a company seeking cost-effective and sustainable manufacturing of a novel protein ingredient that unlocks a range of other healthy and innovative products,” said Mark Warner, founder and CEO of Liberation Labs. “We love what Vivici is doing and will be proud to play a role in their success.”

Liberation Labs is in the late stages of constructing its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 liters and a fully dedicated downstream process (DSP). The plant will produce a range of bio-based materials, including building block ingredients for food, chemicals, and other industrial products at a scale and cost that will fill a pressing need among both new and established consumer packaged goods (CPG) companies and other industrial manufacturers. 

“As awareness of the important role protein plays in supporting active lifestyles continues to grow, American consumers are demanding higher quality and greater quantities of protein in their diets,” said Stephan van Sint Fiet, CEO of Vivici. “Our partnership with Liberation Labs expands our European manufacturing capabilities, providing US customers with increased supply security for Vivitein™ BLG.”